Regulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic beta-cells. 2004

Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
Department of Physiological Sciences, Lund University, BMC B11 SE-22184 Lund, Sweden. matthias.braun@mphy.lu.se

We have explored whether gamma-aminobutyric acid (GABA) is released by regulated exocytosis of GABA-containing synaptic-like microvesicles (SLMVs) in insulin-releasing rat pancreatic beta-cells. To this end, beta-cells were engineered to express GABA(A)-receptor Cl(-)-channels at high density using adenoviral infection. Electron microscopy indicated that the average diameter of the SLMVs is 90 nm, that every beta-cell contains approximately 3,500 such vesicles, and that insulin-containing large dense core vesicles exclude GABA. Quantal release of GABA, seen as rapidly activating and deactivating Cl(-)-currents, was observed during membrane depolarizations from -70 mV to voltages beyond -40 mV or when Ca(2+) was dialysed into the cell interior. Depolarization-evoked GABA release was suppressed when Ca(2+) entry was inhibited using Cd(2+). Analysis of the kinetics of GABA release revealed that GABA-containing vesicles can be divided into a readily releasable pool and a reserve pool. Simultaneous measurements of GABA release and cell capacitance indicated that exocytosis of SLMVs contributes approximately 1% of the capacitance signal. Mathematical analysis of the release events suggests that every SLMV contains 0.36 amol of GABA. We conclude that there are two parallel pathways of exocytosis in pancreatic beta-cells and that release of GABA may accordingly be temporally and spatially separated from insulin secretion. This provides a basis for paracrine GABAergic signaling within the islet.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005089 Exocytosis Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013572 Synaptic Vesicles Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents. Synaptic Vesicle,Vesicle, Synaptic,Vesicles, Synaptic
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
September 1995, Neurochemistry international,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
March 2005, Diabetes,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
May 1991, The EMBO journal,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
May 2014, Cold Spring Harbor protocols,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
July 2010, Journal of neurochemistry,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
October 1998, Methods (San Diego, Calif.),
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
June 1993, Proceedings of the National Academy of Sciences of the United States of America,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
February 2005, The Journal of biological chemistry,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
April 2012, Diabetologia,
Matthias Braun, and Anna Wendt, and Bryndis Birnir, and Jonas Broman, and Lena Eliasson, and Juris Galvanovskis, and Jesper Gromada, and Hindrik Mulder, and Patrik Rorsman
January 1999, International review of cytology,
Copied contents to your clipboard!